June 1, 2023

The American College of Radiology® (ACR®) cosigned a June 1 letter from the American Medical Association to the leadership of the U.S. House Committees on Ways and Means, Energy, and Commerce expressing strong opposition to H.R. 2713, the “Improving Care and Access to Nurses Act,” also referred to as the “I CAN Act.”

The medical associations are concerned this legislation would endanger the quality of care that Medicare and Medicaid patients receive by expanding the scope of practice for non-physician practitioners (NPPs), including nurse practitioners, certified nurse midwives, certified registered nurse anesthetists, clinical nurse specialists and physician assistants. The bill would allow NPPs to perform tasks and services outside their education and training, resulting in increased utilization of services, increased costs, and lower quality of care for patients.

The legislation currently has 11 bipartisan cosponsors, largely from rural areas in their states. ACR continues to monitor this legislation and will provide updates on any action items needed.

For more information, contact Joshua Cooper, ACR Vice President, Congressional Affairs.


Related ACR News

  • Make America Healthy Again

    President Trump released an Executive Order (EO) establishing the "Make America Healthy Again (MAHA) Commission,” Feb. 13 to be led by the new Department of Health and Human Services Secretary Robert F. Kennedy Jr.

    Read more
  • Scope of Practice Bills Introduced At State Legislative Level

    The American College of Radiology® (ACR®) is tracking more than 58 scope of practice bills across 22 states with more expected to be considered.

    Read more
  • ACR Others Challenge MAC Position on Minimally Invasive Arthrodesis of the Sacroiliac Joint

    The American College of Radiology® (ACR®) and other medical specialty societies that use or perform interventional pain and spine procedures told three of the seven Medicare Administrative Contractors (MACs) that implementation of a new policy as written could limit access to a safe, effective and durable treatment option, potentially exacerbating healthcare disparities among Medicare patients.

    Read more